Neuroprotective Effect of the Neuropeptide Cycloprolylglycine Depends on AMPA- and TrkB-Receptor Activation
T A Gudasheva1, K N Koliasnikova2, A G Alyaeva2
1Zakusov Research Institute of Pharmacology, Moscow, Russia. tata-sosnovka@mail.ru.
Abstract:
Previously, we have shown that the endogenous neuropeptide cycloprolylglycine (CPG) is the positive modulator of AMPA receptors and revealed the dependence of its anxiolytic and antihypoxic action on BDNF/Trk signaling. In the present work, we for the first time conducted in vitro experiments using the AMPA receptor blockers DNQX and GYKI 52466 and the Trk receptor blocker K252a. It is shown that the neuroprotective effect of CPG depends on the activation of both AMPA and Trk receptors.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
GPCRs Regulate Adenylyl Cylase Activity
Antiepileptic Drugs: Glutamate Antagonists
cAMP-dependent Protein Kinase Pathways
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists


